| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging.
|
J Am Coll Cardiol
|
2006
|
4.37
|
|
2
|
Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures.
|
Circ Res
|
2008
|
2.80
|
|
3
|
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.
|
Circulation
|
2011
|
2.04
|
|
4
|
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
|
JAMA
|
2009
|
1.99
|
|
5
|
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.
|
Circ Cardiovasc Genet
|
2015
|
1.94
|
|
6
|
MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction.
|
Am Heart J
|
2007
|
1.84
|
|
7
|
Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.
|
Circulation
|
2005
|
1.78
|
|
8
|
In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
|
Catheter Cardiovasc Interv
|
2009
|
1.60
|
|
9
|
Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
|
Am J Cardiol
|
2009
|
1.55
|
|
10
|
Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
|
J Am Coll Cardiol
|
2007
|
1.46
|
|
11
|
Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease.
|
Heart Rhythm
|
2006
|
1.46
|
|
12
|
Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro.
|
Stem Cells
|
2006
|
1.42
|
|
13
|
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
|
Circ Res
|
2015
|
1.39
|
|
14
|
Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures.
|
J Am Coll Cardiol
|
2005
|
1.35
|
|
15
|
Role of imaging in cardiac stem cell therapy.
|
J Am Coll Cardiol
|
2007
|
1.32
|
|
16
|
Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction.
|
Am J Cardiol
|
2007
|
1.31
|
|
17
|
Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
|
Am J Physiol Heart Circ Physiol
|
2009
|
1.22
|
|
18
|
A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
|
Circ Heart Fail
|
2009
|
1.19
|
|
19
|
Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
|
Eur Heart J
|
2004
|
1.16
|
|
20
|
Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling.
|
Cardiovasc Res
|
2006
|
1.16
|
|
21
|
Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin.
|
Cardiovasc Res
|
2005
|
1.12
|
|
22
|
Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteria.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.07
|
|
23
|
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.
|
J Am Coll Cardiol
|
2008
|
1.06
|
|
24
|
New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Circ Arrhythm Electrophysiol
|
2009
|
1.00
|
|
25
|
Cell therapy for ischaemic heart disease.
|
Heart
|
2008
|
1.00
|
|
26
|
Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
|
J Nucl Med
|
2006
|
0.98
|
|
27
|
Gap junctional coupling with cardiomyocytes is necessary but not sufficient for cardiomyogenic differentiation of cocultured human mesenchymal stem cells.
|
Stem Cells
|
2012
|
0.98
|
|
28
|
Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts.
|
PLoS One
|
2011
|
0.98
|
|
29
|
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.
|
J Cardiovasc Transl Res
|
2013
|
0.97
|
|
30
|
Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction.
|
Am J Physiol Heart Circ Physiol
|
2007
|
0.97
|
|
31
|
Engraftment patterns of human adult mesenchymal stem cells expose electrotonic and paracrine proarrhythmic mechanisms in myocardial cell cultures.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.97
|
|
32
|
Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.
|
JACC Cardiovasc Interv
|
2008
|
0.93
|
|
33
|
Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene.
|
FASEB J
|
2007
|
0.92
|
|
34
|
Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function.
|
Circ Cardiovasc Imaging
|
2011
|
0.91
|
|
35
|
Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels.
|
Eur J Heart Fail
|
2007
|
0.91
|
|
36
|
Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.
|
Stem Cells
|
2008
|
0.91
|
|
37
|
Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes.
|
J Cell Mol Med
|
2014
|
0.90
|
|
38
|
A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT.
|
J Nucl Med
|
2006
|
0.90
|
|
39
|
CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.
|
J Mol Cell Cardiol
|
2008
|
0.89
|
|
40
|
Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy.
|
Eur Heart J
|
2011
|
0.89
|
|
41
|
Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study).
|
Am J Cardiol
|
2010
|
0.89
|
|
42
|
Noninvasive and invasive evaluation of noncompaction cardiomyopathy.
|
J Cardiovasc Magn Reson
|
2002
|
0.88
|
|
43
|
Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results.
|
Am Heart J
|
2006
|
0.88
|
|
44
|
Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts.
|
Circulation
|
2007
|
0.88
|
|
45
|
Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts.
|
J Cell Mol Med
|
2012
|
0.88
|
|
46
|
Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
|
Am J Cardiol
|
2006
|
0.88
|
|
47
|
Interaction between myofibroblasts and stem cells in the fibrotic heart: balancing between deterioration and regeneration.
|
Cardiovasc Res
|
2014
|
0.87
|
|
48
|
Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers.
|
Am J Cardiol
|
2013
|
0.86
|
|
49
|
Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy.
|
Eur J Heart Fail
|
2008
|
0.85
|
|
50
|
Bone marrow cell injection for chronic myocardial ischemia: the past and the future.
|
J Cardiovasc Transl Res
|
2011
|
0.85
|
|
51
|
Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients.
|
Int J Cardiovasc Imaging
|
2014
|
0.84
|
|
52
|
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
|
Eur Heart J
|
2009
|
0.84
|
|
53
|
Brief report: Misinterpretation of coculture differentiation experiments by unintended labeling of cardiomyocytes through secondary transduction: delusions and solutions.
|
Stem Cells
|
2012
|
0.84
|
|
54
|
Connexin43 silencing in myofibroblasts prevents arrhythmias in myocardial cultures: role of maximal diastolic potential.
|
Cardiovasc Res
|
2011
|
0.84
|
|
55
|
Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment.
|
EuroIntervention
|
2009
|
0.82
|
|
56
|
Remote monitoring of patients with implanted devices: data exchange and integration.
|
Eur J Prev Cardiol
|
2013
|
0.82
|
|
57
|
Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia.
|
J Magn Reson Imaging
|
2008
|
0.82
|
|
58
|
Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
|
Am J Cardiol
|
2009
|
0.82
|
|
59
|
Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers.
|
PLoS One
|
2012
|
0.81
|
|
60
|
Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization.
|
Cardiovasc Res
|
2011
|
0.81
|
|
61
|
Epithelial-to-mesenchymal transformation alters electrical conductivity of human epicardial cells.
|
J Cell Mol Med
|
2011
|
0.80
|
|
62
|
Role of calcified spots detected by intravascular ultrasound in patients with ST-segment elevation acute myocardial infarction.
|
Am J Cardiol
|
2006
|
0.79
|
|
63
|
Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
|
Am Heart J
|
2012
|
0.79
|
|
64
|
Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms.
|
Cardiovasc Res
|
2012
|
0.79
|
|
65
|
Integrin stimulation favors uptake of macromolecules by cardiomyocytes in vitro.
|
Cell Physiol Biochem
|
2011
|
0.78
|
|
66
|
Post-myocardial infarct inflammation and the potential role of cell therapy.
|
Cardiovasc Drugs Ther
|
2015
|
0.77
|
|
67
|
Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
|
EuroIntervention
|
2012
|
0.76
|
|
68
|
Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia.
|
Acute Card Care
|
2007
|
0.76
|
|
69
|
Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia.
|
Int J Cardiovasc Imaging
|
2014
|
0.76
|
|
70
|
Cell therapy for the treatment of chronic ischemic heart disease.
|
Curr Pharm Des
|
2011
|
0.75
|
|
71
|
Tissue Doppler imaging for detection of myocardial ischemia: are we there yet?
|
Int J Cardiovasc Imaging
|
2003
|
0.75
|
|
72
|
Response to the letter by Rose et al.
|
Circ Res
|
2009
|
0.75
|
|
73
|
Acute myocardial infarction during substitution with recombinant factor VIII concentrate in a patient with mild haemophilia A.
|
Thromb Haemost
|
2004
|
0.75
|
|
74
|
Effect of intracoronary aqueous oxygen on left ventricular remodeling after anterior wall ST-elevation acute myocardial infarction.
|
Am J Cardiol
|
2005
|
0.75
|
|
75
|
Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study.
|
EuroIntervention
|
2009
|
0.75
|
|
76
|
Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia.
|
Int J Cardiol
|
2013
|
0.75
|
|
77
|
Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
|
Catheter Cardiovasc Interv
|
2005
|
0.75
|
|
78
|
Haemodynamics and left ventricular function in heart failure patients: comparison of awake versus intra-operative conditions.
|
Eur J Heart Fail
|
2008
|
0.75
|